| Product Code: ETC10772557 | Publication Date: Apr 2025 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
The import shipments of peripheral intervention drug-eluting devices to New Zealand in 2024 continued to be dominated by key exporting countries such as Australia, Metropolitan France, Spain, Ireland, and Germany. Despite the low concentration of market share, the compound annual growth rate (CAGR) from 2020 to 2024 stood at a steady 3.11%. However, there was a notable decline in the growth rate from 2023 to 2024 at -16.18%, indicating potential shifts in market dynamics that importers and stakeholders may need to navigate.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 New Zealand Peripheral Intervention Drug-Eluting Devices Market Overview |
3.1 New Zealand Country Macro Economic Indicators |
3.2 New Zealand Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, 2022 & 2032F |
3.3 New Zealand Peripheral Intervention Drug-Eluting Devices Market - Industry Life Cycle |
3.4 New Zealand Peripheral Intervention Drug-Eluting Devices Market - Porter's Five Forces |
3.5 New Zealand Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume Share, By Device Type, 2022 & 2032F |
3.6 New Zealand Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume Share, By Coating Material, 2022 & 2032F |
3.7 New Zealand Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.8 New Zealand Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume Share, By End User, 2022 & 2032F |
3.9 New Zealand Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume Share, By Technology, 2022 & 2032F |
4 New Zealand Peripheral Intervention Drug-Eluting Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of peripheral artery diseases in New Zealand |
4.2.2 Technological advancements in drug-eluting devices for peripheral interventions |
4.2.3 Growing demand for minimally invasive procedures in the healthcare sector |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of drug-eluting devices |
4.3.2 High cost associated with drug-eluting devices compared to traditional interventions |
5 New Zealand Peripheral Intervention Drug-Eluting Devices Market Trends |
6 New Zealand Peripheral Intervention Drug-Eluting Devices Market, By Types |
6.1 New Zealand Peripheral Intervention Drug-Eluting Devices Market, By Device Type |
6.1.1 Overview and Analysis |
6.1.2 New Zealand Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Device Type, 2022 - 2032F |
6.1.3 New Zealand Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Drug-Eluting Stents, 2022 - 2032F |
6.1.4 New Zealand Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Drug-Eluting Balloons, 2022 - 2032F |
6.1.5 New Zealand Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Biodegradable Stents, 2022 - 2032F |
6.1.6 New Zealand Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Polymer-Based Stents, 2022 - 2032F |
6.1.7 New Zealand Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Hybrid Coated Stents, 2022 - 2032F |
6.2 New Zealand Peripheral Intervention Drug-Eluting Devices Market, By Coating Material |
6.2.1 Overview and Analysis |
6.2.2 New Zealand Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Sirolimus, 2022 - 2032F |
6.2.3 New Zealand Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Paclitaxel, 2022 - 2032F |
6.2.4 New Zealand Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Everolimus, 2022 - 2032F |
6.2.5 New Zealand Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Zotarolimus, 2022 - 2032F |
6.2.6 New Zealand Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Rapamycin, 2022 - 2032F |
6.3 New Zealand Peripheral Intervention Drug-Eluting Devices Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 New Zealand Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Peripheral Artery Disease, 2022 - 2032F |
6.3.3 New Zealand Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Chronic Limb Ischemia, 2022 - 2032F |
6.3.4 New Zealand Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Deep Vein Thrombosis, 2022 - 2032F |
6.3.5 New Zealand Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Aneurysm Repair, 2022 - 2032F |
6.3.6 New Zealand Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Stenosis Treatment, 2022 - 2032F |
6.4 New Zealand Peripheral Intervention Drug-Eluting Devices Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 New Zealand Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Hospitals, 2022 - 2032F |
6.4.3 New Zealand Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Specialty Clinics, 2022 - 2032F |
6.4.4 New Zealand Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Ambulatory Centers, 2022 - 2032F |
6.4.5 New Zealand Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Research Institutes, 2022 - 2032F |
6.4.6 New Zealand Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Cardiac Care Centers, 2022 - 2032F |
6.5 New Zealand Peripheral Intervention Drug-Eluting Devices Market, By Technology |
6.5.1 Overview and Analysis |
6.5.2 New Zealand Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Nanocoating, 2022 - 2032F |
6.5.3 New Zealand Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Biodegradable Coating, 2022 - 2032F |
6.5.4 New Zealand Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Sustained Drug Release, 2022 - 2032F |
6.5.5 New Zealand Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Polymer-Encapsulated, 2022 - 2032F |
6.5.6 New Zealand Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Targeted Drug Delivery, 2022 - 2032F |
7 New Zealand Peripheral Intervention Drug-Eluting Devices Market Import-Export Trade Statistics |
7.1 New Zealand Peripheral Intervention Drug-Eluting Devices Market Export to Major Countries |
7.2 New Zealand Peripheral Intervention Drug-Eluting Devices Market Imports from Major Countries |
8 New Zealand Peripheral Intervention Drug-Eluting Devices Market Key Performance Indicators |
8.1 Number of new drug-eluting devices introduced to the market |
8.2 Adoption rate of drug-eluting devices in peripheral interventions |
8.3 Average procedure time for using drug-eluting devices in peripheral interventions |
9 New Zealand Peripheral Intervention Drug-Eluting Devices Market - Opportunity Assessment |
9.1 New Zealand Peripheral Intervention Drug-Eluting Devices Market Opportunity Assessment, By Device Type, 2022 & 2032F |
9.2 New Zealand Peripheral Intervention Drug-Eluting Devices Market Opportunity Assessment, By Coating Material, 2022 & 2032F |
9.3 New Zealand Peripheral Intervention Drug-Eluting Devices Market Opportunity Assessment, By Application, 2022 & 2032F |
9.4 New Zealand Peripheral Intervention Drug-Eluting Devices Market Opportunity Assessment, By End User, 2022 & 2032F |
9.5 New Zealand Peripheral Intervention Drug-Eluting Devices Market Opportunity Assessment, By Technology, 2022 & 2032F |
10 New Zealand Peripheral Intervention Drug-Eluting Devices Market - Competitive Landscape |
10.1 New Zealand Peripheral Intervention Drug-Eluting Devices Market Revenue Share, By Companies, 2025 |
10.2 New Zealand Peripheral Intervention Drug-Eluting Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here